More insurance companies plan to drop GLP-1 coverage in 2027

Multiple private insurers have signaled plans to drop coverage for GLP-1 weight-loss drugs, including Wegovy and Zepbound, starting in 2027. This follows employer trends to control soaring pharmacy benefit costs. For practices managing patients on these therapies, this creates a concrete coverage cliff. Audit your patient roster for GLP-1 prescriptions now. Develop a patient communication plan to discuss alternative treatments or appeal pathways before January 1, 2027, when new plan years take effect.